JPS5833202B2 - ガンカヨウシヨホウノ アンテイカホウ - Google Patents

ガンカヨウシヨホウノ アンテイカホウ

Info

Publication number
JPS5833202B2
JPS5833202B2 JP49029246A JP2924674A JPS5833202B2 JP S5833202 B2 JPS5833202 B2 JP S5833202B2 JP 49029246 A JP49029246 A JP 49029246A JP 2924674 A JP2924674 A JP 2924674A JP S5833202 B2 JPS5833202 B2 JP S5833202B2
Authority
JP
Japan
Prior art keywords
oxotremorine
dehydro
gankayoushiyohouno
anteikahou
pilocarpine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49029246A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5035320A (enrdf_load_stackoverflow
Inventor
レイモンド スミシーズ ジヨン
ジヤガンナス ラジヤドハイアクシヤ ビタル
ジエング デア フランク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00341732A external-priority patent/US3824313A/en
Application filed by Allergan Pharmaceuticals Inc filed Critical Allergan Pharmaceuticals Inc
Publication of JPS5035320A publication Critical patent/JPS5035320A/ja
Publication of JPS5833202B2 publication Critical patent/JPS5833202B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
JP49029246A 1973-03-16 1974-03-15 ガンカヨウシヨホウノ アンテイカホウ Expired JPS5833202B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00341732A US3824313A (en) 1973-03-16 1973-03-16 Topical opthalmic composition and methods of use
US44568574A 1974-02-25 1974-02-25

Publications (2)

Publication Number Publication Date
JPS5035320A JPS5035320A (enrdf_load_stackoverflow) 1975-04-04
JPS5833202B2 true JPS5833202B2 (ja) 1983-07-18

Family

ID=26992634

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49029246A Expired JPS5833202B2 (ja) 1973-03-16 1974-03-15 ガンカヨウシヨホウノ アンテイカホウ

Country Status (7)

Country Link
JP (1) JPS5833202B2 (enrdf_load_stackoverflow)
CA (1) CA1024070A (enrdf_load_stackoverflow)
DE (1) DE2411019C2 (enrdf_load_stackoverflow)
DK (1) DK136884B (enrdf_load_stackoverflow)
ES (1) ES424362A1 (enrdf_load_stackoverflow)
FR (1) FR2221140B1 (enrdf_load_stackoverflow)
GB (1) GB1459264A (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140009163A (ko) 2010-09-30 2014-01-22 솔베이(소시에떼아노님) 천연유래 에피클로로히드린의 유도체
WO2020072971A1 (en) * 2018-10-06 2020-04-09 Biotheravision Llc Ophthalmic preparations of muscarinic agonist and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE300422B (enrdf_load_stackoverflow) * 1964-07-03 1968-04-29 Astra Ab

Also Published As

Publication number Publication date
DE2411019C2 (de) 1986-11-20
DE2411019A1 (de) 1974-09-26
FR2221140A1 (enrdf_load_stackoverflow) 1974-10-11
GB1459264A (en) 1976-12-22
AU6679074A (en) 1975-09-18
DK136884B (da) 1977-12-12
FR2221140B1 (enrdf_load_stackoverflow) 1977-07-01
CA1024070A (en) 1978-01-10
ES424362A1 (es) 1976-10-16
JPS5035320A (enrdf_load_stackoverflow) 1975-04-04

Similar Documents

Publication Publication Date Title
JP5174777B2 (ja) Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
US4127674A (en) Method of treatment for glaucoma
CN110396085A (zh) 联合治疗
EP1889620A1 (en) Eye drop containing roflumilast
CA2506464C (en) Therapeutic agent for glaucoma comprising rho kinase inhibitor and .beta.-blocker
US4197301A (en) Topical ophthalmic use of Prazosin
US5438060A (en) Method of reducing elevated intraocular pressure
US3885047A (en) Ocular hypotensive process employing dextrorotatory phenethanolamines
US4275074A (en) Catecholamine treatment of ocular hypertension
US3985897A (en) Ocular hypotensive process employing dextrorotatory sulfonamidophenethanolamines
EP0081581B1 (en) Compositions for treating glaucoma
US3991206A (en) Alleviation of eye inflammation by topical application of p-biphenylacetic acid
JPS5833202B2 (ja) ガンカヨウシヨホウノ アンテイカホウ
US4590210A (en) Compositions for treatment of ocular hypertension
JPS588013A (ja) 緑内障および高眼圧症の治療用薬学的調合物
US3920824A (en) Stable ophthalmic formulation
JP4300347B2 (ja) ブナゾシンとプロスタグランジン類からなる緑内障治療剤
US3670087A (en) Method of lowering intraocular pressure
US3933998A (en) 4-[2-(Isopropylamino)ethyl]pyrocatechol intraocular pressure lowering process
US3824313A (en) Topical opthalmic composition and methods of use
EP1200079B1 (en) 2-aminotetralin derivatives for the therapy of glaucoma
EP0728480A1 (en) Use of ifenprodil for treatment of elevated intraocular pressure
EP0067910B1 (en) Compounds and compositions for treatment of ocular hypertension
WO1980000215A1 (en) Medicament against glaucoma
JPS5951927B2 (ja) 緑内障治療剤